Intensified ChlVPP/ABVVP chemotherapy regimen and pegfilgrastim support in advanced Hodgkin lymphoma

about

Intensified ChlVPP/ABVVP chemotherapy regimen and pegfilgrastim support in advanced Hodgkin lymphoma

Item

http://www.wikidata.org/entity/Q35602142

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Intensified ChlVPP/ABVVP chemo ...... t in advanced Hodgkin lymphoma

@ast

Intensified ChlVPP/ABVVP chemo ...... t in advanced Hodgkin lymphoma

@en

type

Item

label

Intensified ChlVPP/ABVVP chemo ...... t in advanced Hodgkin lymphoma

@ast

Intensified ChlVPP/ABVVP chemo ...... t in advanced Hodgkin lymphoma

@en

prefLabel

Intensified ChlVPP/ABVVP chemo ...... t in advanced Hodgkin lymphoma

@ast

Intensified ChlVPP/ABVVP chemo ...... t in advanced Hodgkin lymphoma

@en

P1476

Intensified ChlVPP/ABVVP chemo ...... t in advanced Hodgkin lymphoma

@en

P2093

A Vanazzi

http://www.w3.org/2001/XMLSchema#string

E Botteri

http://www.w3.org/2001/XMLSchema#string

E Cocorocchio

http://www.w3.org/2001/XMLSchema#string

F Gigli

http://www.w3.org/2001/XMLSchema#string

G Martinelli

http://www.w3.org/2001/XMLSchema#string

G Piperno

http://www.w3.org/2001/XMLSchema#string

G Pruneri

http://www.w3.org/2001/XMLSchema#string

L Travaini

http://www.w3.org/2001/XMLSchema#string

M Negri

http://www.w3.org/2001/XMLSchema#string

P Antoniotti

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD

Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP

ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease.

Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.

Long-term outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma.

Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.

Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma

Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia.

Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease.

P304

184

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3332/ECANCER.2010.184

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lorenzo Preda

Fedro A Peccatori

P577

2010-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221776241

http://www.w3.org/2001/XMLSchema#string

P698

22276036

http://www.w3.org/2001/XMLSchema#string

P932

3234024

http://www.w3.org/2001/XMLSchema#string